All news

Ninety One trims Edwards Lifesciences stake by 5.6%

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Ninety One North America Inc. cut its Edwards Lifesciences (NYSE:EW) stake by 5.6% in the third quarter of 2026, selling 34,328 shares while retaining a holding valued at $50.3 million. Institutions own 79.46% of the company. Edwards posted stronger-than-expected quarterly earnings and revenue, and analysts hold a Moderate Buy rating with an average price target of

Read original source

EW company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.